Related Experiment Video
Updated: Aug 3, 2026
09:36
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
Published on: October 16, 2010
Selenium in human mammary carcinogenesis: a case-referent study
K Overvad1, P Grøn, O Langhoff
1Institute of Social Medicine, University of Aarhus, Denmark.
Summary
Serum selenium levels did not correlate with breast cancer risk in a case-referent study. This research on selenium and mammary carcinogenesis found no significant association in early-stage patients.
Area of Science:
- Oncology
- Nutritional Biochemistry
Background:
- Selenium is an essential trace element with antioxidant properties.
- Its role in human mammary carcinogenesis remains under investigation.
- Previous studies suggest potential links between selenium and cancer risk.
Purpose of the Study:
- To investigate the association between serum selenium levels and the risk of human breast cancer.
- To evaluate selenium as a potential biomarker for breast cancer.
- To explore disease-mediated changes in selenium levels during carcinogenesis.
Main Methods:
- A case-referent study design was employed.
- Serum selenium concentrations were measured in breast cancer cases and referents.
- Statistical analyses, including multiple logistic regression, were performed.
- Analysis was stratified by TNM staging to account for disease progression.
Main Results:
- Mean serum selenium was similar between cases (79 ± 12 µg/l) and referents (81 ± 12 µg/l).
- A trend of decreasing serum selenium was observed in cases from TNM stage I to stage II.
- No significant association was found between serum selenium levels and breast cancer risk in TNM stage I patients.
Conclusions:
- Serum selenium levels do not appear to be a significant risk indicator for human breast cancer.
- Observed changes in selenium levels among cases may be secondary to the disease process.
- Further research is needed to fully elucidate the role of selenium in mammary carcinogenesis.
